Concourse Financial Group Securities, Inc. Biogen Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 22 shares of BIIB stock, worth $4,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 25 12.0%

Holding current value

$4,431

Previous $5,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$190.52 - $236.72 $571 - $710	-3 Reduced 12.0%	22 $5,000
Q1 2024 Apr 30, 2024	SELL	$212.02 - $267.71 $8,692 - $10,976	-41 Reduced 62.12%	25 $5,000
Q4 2023 Feb 07, 2024	SELL	$222.59 - $267.94 $1,335 - $1,607	-6 Reduced 8.33%	66 $17,000
Q3 2023 Oct 25, 2023	BUY	$253.3 - $285.89 $10,638 - $12,007	42 Added 140.0%	72 $18,000
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $825 - $954	3 Added 11.11%	30 $8,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $1,282 - $1,461	5 Added 22.73%	27 $7,000
Q4 2022 Jan 30, 2023	BUY	$252.44 - $306.72 $1,767 - $2,147	7 Added 46.67%	22 $0
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $11,044 - $13,915	-57 Reduced 79.17%	15 $3,000
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $22,392 - $28,777	-100 Reduced 58.14%	72 $17,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $28,299 - $36,905	100 Added 138.89%	172 $49,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $32,116 - $51,424	-124 Reduced 63.27%	72 $24,000
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $12,390 - $14,516	51 Added 35.17%	196 $55,000
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $472 - $711	-2 Reduced 1.36%	145 $36,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $30,978 - $35,768	-117 Reduced 44.32%	147 $42,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $5,431 - $7,193	-21 Reduced 7.37%	264 $71,000
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $6,452 - $8,184	-24 Reduced 7.77%	285 $90,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $25,967 - $35,880	118 Added 61.78%	309 $92,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $71,972 - $80,724	-331 Reduced 63.41%	191 $44,000
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $59,208 - $65,264	270 Added 107.14%	522 $122,000
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $23,621 - $36,946	109 Added 76.22%	252 $59,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $12,532 - $15,873	45 Added 45.92%	143 $43,000
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $28,763 - $37,615	98 New	98 $35,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Biogen Inc. Transaction History